Rifaximin plus fibre versus fibre alone in preventing diverticulitis recurrence: a (problematic) trial to tackle an epidemiologically relevant problem

Dig Liver Dis. 2013 Feb;45(2):102-3. doi: 10.1016/j.dld.2012.12.003. Epub 2013 Jan 5.
No abstract available

Publication types

  • Comment

MeSH terms

  • Dietary Fiber / therapeutic use*
  • Diverticulitis / drug therapy*
  • Female
  • Gastrointestinal Agents / therapeutic use*
  • Humans
  • Male
  • Rifamycins / therapeutic use*
  • Rifaximin

Substances

  • Dietary Fiber
  • Gastrointestinal Agents
  • Rifamycins
  • Rifaximin